Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (OTCQX: CURLF, TSX: CURA) generates frequent news as an international provider of consumer cannabis products operating across medical and adult-use markets. Company updates often highlight its portfolio of brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company, and how these brands are deployed through retail dispensaries and international channels.
News coverage for Curaleaf commonly includes corporate and regulatory developments, such as its announced intention to seek shareholder approval for a proposed arrangement to continue from British Columbia, Canada to Delaware in the United States. This proposed domestication is described by the company as a way to align its corporate structure with its operational focus while maintaining its listings on the Toronto Stock Exchange and OTCQX.
Investors and observers can also expect retail expansion and operational updates. Recent announcements have covered the opening and relocation of dispensaries, including Curaleaf Millcreek in Erie, Pennsylvania, and Curaleaf Cape Canaveral in Florida. These releases describe new store locations, in-store experience, and the availability of products such as premium flower, vapes and edibles under the company’s brands.
Curaleaf’s news flow further includes transaction and financing announcements, such as its binding commitment to acquire, and later the termination of that commitment for, The Cannabist Company’s Virginia assets, and the upsizing of its revolving credit facility with Needham Bank from $40 million to $100 million. In addition, the company issues financial results releases, including quarterly reports prepared under U.S. GAAP that detail segment revenue, margins, cash flow and non-GAAP performance measures.
Beyond financial and operational items, Curaleaf also reports on community and social initiatives like its Feed the Block fundraiser to address food insecurity and partnerships with organizations such as the Baldwin Fund. For those tracking CURLF, this news page brings together these various categories of updates in one place.
Curaleaf (OTCQX: CURLF) announced on December 19, 2025 that it has terminated its binding commitment to acquire The Cannabist Company's Virginia assets.
A competing bid valued the Virginia assets at $130 million plus assumption of a $30 million lease liability, which Curaleaf said exceeded its assessment of fair value. Curaleaf expects to receive a $3.3 million break fee upon cancellation and said it will remain opportunistic and disciplined in pursuing future acquisitions.
Curaleaf (OTCQX: CURLF) applauded the Trump Administration's December 18, 2025 rescheduling of cannabis to Schedule III under the Controlled Substances Act.
The company said the reclassification should enable federally funded clinical research, expand patient access, support veterans, remove onerous tax penalties, and create opportunities for investment, jobs, and local tax revenue. Curaleaf's chairman and CEO praised the move as aligning federal policy with scientific understanding and widespread public support.
Curaleaf (OTCQX:CURLF) opened a new dispensary in Cape Canaveral, Florida at 6710 N Atlantic Avenue on Dec. 4, 2025, expanding its Florida footprint to 70 stores and its national footprint to 159 locations.
Curaleaf Cape Canaveral will offer Anthem pre-rolls, Grassroots Dark Heart, Select Briq, Select ACE, Reef and other flower, vape, and edible products. Hours are Monday–Saturday 9:00 a.m.–8:30 p.m. and Sunday 10:00 a.m.–7:00 p.m. A grand opening and ribbon-cutting is scheduled for Friday, December 12 with promotions and giveaways.
Curaleaf (OTCQX: CURLF) entered a binding commitment to acquire The Cannabist Company’s Virginia assets, including a fully operational cultivation facility, five retail dispensaries and the right to open one additional dispensary.
Curaleaf expects the transaction to close in the first quarter of 2026, subject to customary closing conditions and a 15-business-day go-shop period that ends December 22, 2025 at 11:59 p.m. ET. If a competing bid is accepted during the go-shop or if noteholder consent is not obtained, Curaleaf is entitled to a $3.3 million break-up fee plus up to $350,000 of associated expenses.
Curaleaf (OTCQX: CURLF) reported Q3 2025 net revenue of $320.2M and adjusted gross profit margin of 50%, up ~115 basis points year‑over‑year. Adjusted EBITDA was $69.3M (21.6% margin). Cash at quarter end was $107.5M and year‑to‑date operating and free cash flow from continuing operations were $104.0M and $56.8M, respectively. International revenue grew strongly ($45.99M Q3; $121.8M YTD). Curaleaf upsized its revolving credit to $100M post‑quarter.
Curaleaf (OTCQX: CURLF) launched its fifth annual Feed the Block fundraiser on Nov. 3, 2025, a nationwide campaign to address food insecurity during November–December across 12 states. Since 2020 the program has raised more than $450,000 and provided meals to thousands of families.
Customers can round up purchases or donate at participating dispensaries; 100% of donations go to local food-relief organizations. Team members will also run food drives and volunteer events.
Curaleaf (OTCQX: CURLF) announced an amended and restated secured revolving credit agreement with Needham Bank on October 14, 2025, increasing capacity from $40 million to $100 million and extending the potential maturity to up to five years. The facility carries an initial one-year term with interest at 7.99% and a potential step-up to 8.99% if the company refinances its Senior Note due 2026. Curaleaf plans to use the new capacity to pay at least $50 million of remaining higher-interest acquisition-related debt while preserving liquidity for working capital and growth initiatives. The company describes the transaction as the largest U.S. cannabis-sector revolving facility to date, intended to broaden institutional lending access for the industry.
Curaleaf Holdings (OTCQX: CURLF), a leading international cannabis products provider, announced that Executive Vice Chairman Joseph F. Lusardi has established an Automatic Securities Disposition Plan (ASDP) effective September 30, 2025.
The ASDP will facilitate the orderly exercise of options expiring in March 2026 and the sale of some subordinate voting shares to cover anticipated taxes. Sales will begin on January 2, 2026, continuing over three months at prevailing market prices.
The plan follows securities regulations and company trading policies, allowing pre-arranged share sales when executives aren't privy to undisclosed material information. An independent broker will execute trades within set parameters, with no further input from Lusardi.
Curaleaf (OTCQX: CURLF), a leading cannabis products provider, has announced its partnership with The Carol M. Baldwin Breast Cancer Research Fund for Breast Cancer Action Month in October 2025. The "Round Up for Research" initiative will be implemented across 13 states, allowing customers to round up their purchases at checkout to support breast cancer research at Upstate Medical University.
The Baldwin Fund has historically raised over $13 million for breast cancer research and is currently pursuing a $50 million campaign to help Upstate Cancer Center achieve National Cancer Institute designation. The program will be available in Arizona, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Nevada, New Jersey, New York, North Dakota, Pennsylvania, and Utah.
Curaleaf Holdings (OTCQX: CURLF) has launched Anthem Bold, a new premium infused pre-roll line expanding its Anthem brand portfolio. The product is now available at Curaleaf dispensaries in Arizona, Illinois, New Jersey, and New York, with wholesale distribution planned.
Anthem Bold infuses premium flower with THCA diamonds and strain-specific terpenes, delivering around 40% THC. The product comes in two formats: sweet wood tip and glass tip options, available in half-gram 5-packs and one-gram single pre-rolls. The launch is significant as pre-rolls represent the fastest-growing cannabis category, with infused pre-rolls accounting for 45% of overall pre-roll sales, reaching up to 70% in some markets.